ON THE DETERMINATION OF THE EFFECTIVE TRANSMISSION FACTOR FOR STAINLESS-STEEL OVOID SHIELDING SEGMENTS AND ESTIMATION OF THEIR SHIELDING EFFICACY FOR THE CLINICAL SITUATION

被引:15
作者
VERELLEN, D [1 ]
DENEVE, W [1 ]
VANDENHEUVEL, F [1 ]
STORME, G [1 ]
COEN, V [1 ]
COGHE, M [1 ]
机构
[1] STATE UNIV GHENT HOSP,DEPT RADIOTHERAPY & NUCL MED,B-9000 GHENT,BELGIUM
关键词
BRACHYTHERAPY; GYNECOLOGICAL APPLICATORS; SHIELDING; DOSIMETRY;
D O I
10.1118/1.597281
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Commercially available ovoid tubes for gynecological applications used in conjunction with the microSelectron-HDR (Nucletron International B.V., Waardegelder 1, 3905 TH Veenendaal, The Netherlands) for 192Ir sources, allow for shielding. Publications concerning the transmission properties of these 4.5-mm thick stainless steel (AISI number 303/304) shielding segments are scarce and not compatible for implementation in treatment planning. Therefore the effect of shielding on dose distribution is unknown. The effective transmission factor has been measured and implemented in the planning computations. Screening efficacy was evaluated on 20 actual treatment plans, analyzing dose reduction to critical tissue and comparing dose distribution in planes relevant for this particular application. Due to high transmission (effective transmission factor=0.85), stainless steel screening segments only provide low, local dose reductions of maximum 15%. A new approach with regard to optimization and source configuration is needed to reduce dose to vulnerable tissue, exploiting the screening segments to a maximum extent. Better shielding, especially at the midline (plane bisecting the ovoids) could be expected by using shielding segments with other geometrical characteristics. © 1994, American Association of Physicists in Medicine. All rights reserved.
引用
收藏
页码:1677 / 1684
页数:8
相关论文
共 21 条
[1]  
ALKEMADE CTJ, 1970, INLEIDING FYSISCHE M
[2]  
BATLEY F, 1967, Journal of the Canadian Association of Radiologists, V18, P396
[3]  
CHASSAGNE D, 1977, J RADIOL ELEC MED N, V58, P371
[4]   CERVICAL RADIUM APPLICATORS WITH SCREENING IN THE DIRECTION OF BLADDER AND RECTUM [J].
FLETCHER, GH .
RADIOLOGY, 1953, 60 (01) :77-84
[5]   DOSIMETRIC COMPARISON OF THE FLETCHER FAMILY OF GYNECOLOGIC COLPOSTATS 1950-1980 [J].
HAAS, JS ;
DEAN, RD ;
MANSFIELD, CM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (07) :1317-1321
[6]  
KHAN FM, 1984, PHYSICS RAD THERAPY
[7]   CT-ASSISTED ASSESSMENT OF BLADDER AND RECTUM DOSE IN GYNECOLOGICAL IMPLANTS [J].
LING, CC ;
SCHELL, MC ;
WORKING, KR ;
JENTZSCH, K ;
HARISIADIS, L ;
CARABELL, S ;
ROGERS, CC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (10) :1577-1582
[8]   MEASUREMENT OF DOSE DISTRIBUTION AROUND FLETCHER-SUIT-DELCOS COLPOSTATS USING A THERADOS RADIATION-FIELD ANALYZER (RFA-3) [J].
LING, CC ;
SPIRO, IJ ;
KUBIATOWICZ, DO ;
GERGEN, J ;
PEKSENS, RK ;
BENNETT, JD ;
GAGNON, WF .
MEDICAL PHYSICS, 1984, 11 (03) :326-330
[9]   SCREENS IN OVOIDS OF A SELECTRON CERVIX APPLICATOR [J].
MEERTENS, H ;
VANDERLAARSE, R .
RADIOTHERAPY AND ONCOLOGY, 1985, 3 (01) :69-80
[10]   ON THE CHOICE OF PHANTOM MATERIAL FOR THE DOSIMETRY OF IR-192 SOURCES [J].
MELI, JA ;
MEIGOONI, AS ;
NATH, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 14 (03) :587-594